(Q48579211)

English

Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

cerebral infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eric T MacKenzie

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

object named as

Thomas Freret

1

0 references

object named as

Samuel Valable

2

0 references

Myriam Bernaudin

object named as

Myriam Bernaudin

7

0 references

author name string

Laurent Chazalviel

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

Romaric Saulnier

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

Edwige Petit

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

Michel Boulouard

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

Pascale Schumann-Bard

9

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

European Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

23

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

1757-1765

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen Stroke Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

HIF1 and oxygen sensing in the brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Oxidants, antioxidants and the ischemic brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04699.X

21 January 2018

Identifiers

10.1111/J.1460-9568.2006.04699.X

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/16623832

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48579211&oldid=1584423208"